EMA approves phage therapy guidelines for veterinary medicine

The European Medicines Agency (EMA) has adopted recommendations on the quality, safety, and efficacy of bacteriophages as veterinary medicines.

The organization said it hopes to encourage the development of such innovative therapies, offering the necessary support to developers in bringing phage therapy products to the European market. 

The document can be viewed at the following link.